Hans Clevers

Last updated

Hans Clevers
Hans Clevers (2018).jpg
Clevers in 2018
Born
Johannes Carolus Clevers [1]

(1957-03-27) 27 March 1957 (age 67) [2] [3] [4]
Eindhoven, Netherlands [2] [3]
NationalityDutch
Alma mater University of Utrecht
Known for Organoid generation and application
SpouseEefke Petersen [5]
Children2 [2]
Awards Louis-Jeantet Prize for Medicine
Breakthrough Prize in Life Sciences
Dr A. H. Heineken Prize for Medicine
Körber European Science Prize
Scientific career
Fields Molecular genetics
Cell biology
Institutions Roche
Princess Máxima Center  [ nl ]
University Medical Center Utrecht
Hubrecht Institute for Developmental Biology and Stem Cell Research
Utrecht University
Dana–Farber Cancer Institute
Thesis Early events in lymphocyte activation  (1985)
Doctoral advisor Rudy Ballieux [6]

Johannes (Hans) Carolus Clevers (born 27 March 1957) [2] [3] is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022. [7] [8] Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research [9] and at the Princess Máxima Center  [ nl ]; [10] he remained as an advisor and guest scientist or visiting researcher to both groups. [7] He is also a Professor in Molecular Genetics at the University of Utrecht. [8]

Contents

Early life and education

Hans Clevers was born in Eindhoven, the Netherlands in 1957. [4] He began studying biology at the University of Utrecht in 1975, but also started taking medicine in 1978, [7] in part due to his interest and in part because his friends and brothers were in the medical profession. [11] He spent 1 year in Nairobi, Kenya, and half a year at the National Institutes of Health in Bethesda, United States, for biology rotations. [11] [12] He received a Doctoraal (equivalent to an MSc) in Biology in 1982 and an Artsexamen (equivalent to an MD) in 1984. Mostly because of his research background, Clevers was selected for a training position in paediatrics, and then went to pursue a PhD in 1985, under the supervision of Rudy Ballieux. [6] [13] [14] He obtained his PhD 1 year later. [7] [11]

Career

After his PhD, Clevers went to the Dana–Farber Cancer Institute as a postdoctoral researcher at Cox Terhorst's group. [8] [11] [15] [16] In 1989, he returned to the Netherlands, joining his alma mater , the University of Utrecht, as an assistant professor at the Department of Clinical Immunology. [8]

In 1991, Clevers became a professor and the chair of the Department of Immunology at the University of Utrecht. [8] He moved to the University Medical Center Utrecht in 2002 as a professor in molecular genetics, and started his lab at the Hubrecht Institute for Developmental Biology and Stem Cell Research (Hubrecht Institute). [7] At the same time, he took up the position of Director of the Hubrecht Institute. [8]

In March 2012, Clevers was elected the president of the Royal Netherlands Academy of Arts and Sciences, succeeding Robbert Dijkgraaf. [17] [18] His term concluded in 2015, and he started another lab at the Princess Máxima Center  [ nl ], [8] focusing on childhood cancer, [10] and became the Director Research and Chief Scientific Officer there until 2019. [8]

Clevers left University Medical Center Utrecht and was appointed Professor in Molecular Genetics at the University of Utrecht in 2020. [7]

In 2022, Clevers joined the Swiss healthcare company Roche as its Head of Pharma, Research and Early Development and a member of its Corporate Executive Committee. [19] [20] He remains an advisor and guest scientist or visiting researcher to his research groups at the Princess Máxima Center and Hubrecht Institute. [9] [10]

Since 2017, Clevers is an investigator at the Oncode Institute in Utrecht. [7] [21]

Clevers has served at a number of scientific organizations, including on the board of directors of the American Association for Cancer Research (2013-2016), [22] and the Scientific Advisory Board of the Swiss Institute for Experimental Cancer Research at the École Polytechnique Fédérale de Lausanne (2005-2015), [8] the Research Institute of Molecular Pathology in Vienna (2015-2021) [23] and the Francis Crick Institute in London. [24] He is currently on the advisory board of various scientific journals, including The EMBO Journal , [25] Disease Models & Mechanisms , [26] Cell , [27] Cell Stem Cell [28] and EMBO Molecular Medicine . [29] From 2014 to 2022, he was also on the editorial committee of the Annual Review of Cancer Biology . [7]

Outside the academia, Clevers has been a scientific advisor to numerous biotechnology companies. [7] He also co-founded California-based Surrozen [30] in 2016 [31] and Shanghai-based D1 Medical Technology [32] in 2019. [33]

Hans Clevers interviewed for the Dutch television show The Mind of the Universe

Research

Clevers's early career focused on the Wnt signaling pathway. [34] His group identified the TCF1 protein, a member of the TCF gene family and a crucial downstream component of the Wnt signaling pathway, making it central in immune responses, embryonic development and tissue repair. [35] His interest in the gastrointestinal tract began with the discovery that another TCF family member, the TCF4 protein, is required in forming intestinal crypts. [36] Collaborating with Bert Vogelstein, he found that in colon cancer where the APC gene is doubly mutated, TCF family members activate catenin beta-1, which then enhances the expression of many genes that cause cancer transformation, [37] connecting the Wnt signaling pathway with colon cancer.

In 2007, Clevers's group identified a marker for stem cells of the small and large intestines, LGR5, itself also a target of the Wnt signaling pathway. [38] This led to his finding that LGR5 is a stem cell marker in other organs as well, including the stomach [39] and hair follicles. [40]

Building on this discovery, in 2009, his group published a landmark paper, describing for the first time how organoids, which are 3-dimensional in vitro structures that behave anatomically and molecularly like the organ from which they are derived, were generated from adult stem cells, creating organoids of the small intestine. [41] Clevers's group has applied this technology to culturing organoids from other organs, such as the stomach [39] and liver, [42] as well as from various cancer types, including cancer of the breast [43] and the ovaries. [44] This platform has since been applied in personalized medicine, by generating organoids from specific patients to screen for drugs. [45] [46] This is not limited to cancer but is applicable to other diseases as well (for example, cystic fibrosis). [47] His current major research interest is in using organoids derived from adult stem cells to study the molecular mechanism of tissue and cancer development.

During the COVID-19 pandemic, Clevers's group modelled the infection of SARS-CoV-2 using lung organoids. [48]

Honours and awards

Related Research Articles

<span class="mw-page-title-main">Organoid</span> Miniaturized and simplified version of an organ

An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural and biological complexity of that organ. They are derived from one or a few cells from a tissue, embryonic stem cells or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and The Scientist names it as one of the biggest scientific advancements of 2013. Scientists and engineers use organoids to study development and disease in the laboratory, drug discovery and development in industry, personalized diagnostics and medicine, gene and cell therapies, tissue engineering and regenerative medicine.

The Cancer Genome Project is part of the cancer, aging, and somatic mutation research based at the Wellcome Trust Sanger Institute in the United Kingdom. It aims to identify sequence variants/mutations critical in the development of human cancers. Like The Cancer Genome Atlas project within the United States, the Cancer Genome Project represents an effort in the War on Cancer to improve cancer diagnosis, treatment, and prevention through a better understanding of the molecular basis of the disease. The Cancer Genome Project was launched by Michael Stratton in 2000, and Peter Campbell is now the group leader of the project. The project works to combine knowledge of the human genome sequence with high throughput mutation detection techniques.

<span class="mw-page-title-main">Ronald Plasterk</span> Dutch politician and scientist (born 1957)

Ronald Hans Anton Plasterk is a Dutch scientist, entrepreneur and retired politician of the Labour Party (PvdA). He has earned a PhD degree in biology, specialised in molecular genetics. Being a former Minister in the Cabinet of the Netherlands, he has been the founder and CEO of Frame Cancer Therapeutics since December 2018. Next to his work at Frame, he has been appointed as professor at the University of Amsterdam since September 2018.

<span class="mw-page-title-main">TCF7L2</span> Protein-coding gene in humans

Transcription factor 7-like 2 , also known as TCF7L2 or TCF4, is a protein acting as a transcription factor that, in humans, is encoded by the TCF7L2 gene. The TCF7L2 gene is located on chromosome 10q25.2–q25.3, contains 19 exons. As a member of the TCF family, TCF7L2 can form a bipartite transcription factor and influence several biological pathways, including the Wnt signalling pathway.

<span class="mw-page-title-main">Alexander van Oudenaarden</span> Dutch biophysicist and systems biologist

Alexander van Oudenaarden is a Dutch biophysicist and systems biologist. He is a leading researcher in stem cell biology, specialising in single cell techniques. In 2012 he started as director of the Hubrecht Institute and was awarded three times an ERC Advanced Grant, in 2012, 2017, and 2022. He was awarded the Spinoza Prize in 2017.

<span class="mw-page-title-main">Institute of Molecular Biotechnology</span> Austrian biomedical research organisation

The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.

<span class="mw-page-title-main">TCF/LEF family</span> Group of genes

The TCF/LEF family is a group of genes that encode transcription factors which bind to DNA through a SOX-like high mobility group domain. They are involved in the Wnt signaling pathway, particularly during embryonic and stem-cell development, but also had been found to play a role in cancer and diabetes. TCF/LEF factors recruit the coactivator beta-catenin to enhancer elements of genes they target. They can also recruit members of the Groucho family of corepressors.

<span class="mw-page-title-main">Siddhartha Mukherjee</span> Indian-American physician, writer b. 1970

Siddhartha Mukherjee is an Indian-American physician, biologist, and author. He is best known for his 2010 book, The Emperor of All Maladies: A Biography of Cancer, that won notable literary prizes including the 2011 Pulitzer Prize for General Non-Fiction, and Guardian First Book Award, among others. The book was listed in the "All-Time 100 Nonfiction Books" by Time magazine in 2011. His 2016 book The Gene: An Intimate History made it to #1 on The New York Times Best Seller list, and was among The New York Times 100 best books of 2016, and a finalist for the Wellcome Trust Prize and the Royal Society Prize for Science Books.

<span class="mw-page-title-main">TCF7L1</span> Protein-coding gene in the species Homo sapiens

Transcription factor 7-like 1, also known as TCF7L1, is a human gene.

<span class="mw-page-title-main">Melissa Little</span> Australian scientist and academic (born 1963)

Melissa Helen Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.

Owen Sansom, FRSE., FMedSci is the Director of the Cancer Research UK Beatson Institute. He is known for his work determining the molecular hallmarks of colorectal cancer (CRC), including demonstrating the roles of the tumour suppressor protein APC and the WNT signalling pathway, as well as the involvement of intestinal stem cells in tumourigenesis

Peter J. Peters is a professor of nanobiology and a distinguished university professor at Maastricht University. Peters is best known for his work in electron microscopy (EM) and cellular immunology. He is the founder and director of the Institute of Nanoscopy.

Vivian Li is a Hong Kong-born cell and developmental biologist working in cancer research at London's Francis Crick Institute. She has been researching how stem cells in the human bowel are programmed to ensure a healthy organ and what goes wrong when cancer develops. She is known for her work on the Wnt signalling pathway, discovering a new way that a molecule called Wnt is activated in bowel cancer. She won a Future Leaders in Cancer Research Prize in part for this discovery.

<span class="mw-page-title-main">Jürgen Knoblich</span> German molecular biologist

Jürgen Knoblich is a German molecular biologist. Since 2018, he is the interim Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.  

<span class="mw-page-title-main">Christine L. Mummery</span>

Christine L. Mummery (1953) is an appointed professor of Developmental Biology at Leiden University and the head of the Department of Anatomy and Embryology at Leiden University Medical Center in the Netherlands.

<span class="mw-page-title-main">Dannielle Engle</span> American biologist

Dannielle Engle is an American biologist and assistant professor of the regulatory biology laboratory at the Salk Institute for Biological Studies. Engle's research aims at improving detection and treatment of pancreatic cancer.

Matthias Lutolf is a bio-engineer and a professor at EPFL where he leads the Laboratory of Stem Cell Bioengineering. He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models. In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.

Intestines-on-a-chip are microfluidic bioengineered 3D-models of the real organ, which better mimic physiological features than conventional 3D intestinal organoid culture. A variety of different intestine-on-a-chip models systems have been developed and refined, all holding their individual strengths and weaknesses and collectively holding great promise to the ultimate goal of establishing these systems as reliable high-throughput platforms for drug testing and personalised medicine. The intestine is a highly complex organ system performing a diverse set of vital tasks, from nutrient digestion and absorption, hormone secretion, and immunological processes to neuronal activity, which makes it particularly challenging to model in vitro.

Meritxell Huch is a stem cell biologist and director at the Max Planck Institute of Molecular Cell Biology and Genetics. Her research considers tissue regeneration and the development of tissue-specific disease models for human organs. She was awarded a European Research Council Consolidator Grant in 2023.

References

  1. 1 2 "Johannes Carolus Clevers". American Academy of Arts and Sciences. Archived from the original on 27 June 2022.
  2. 1 2 3 4 "2016 – Johannes C. Clevers". Ilse & Helmut Wachter Foundation, Medical University of Innsbruck. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  3. 1 2 3 "Prof.dr. J.C. Clevers" (in Dutch). Utrecht University. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  4. 1 2 "Prof. dr. J.C. (Hans) Clevers" (in Dutch). University Medical Center Utrecht. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  5. ↑ Clevers, Hans (1 October 2021). "The development of organoids for cancer research: an ode to the scientific method". Cancer World. Archived from the original on 29 June 2022. Retrieved 29 June 2022.
  6. 1 2 "Mentoring the Next Generation: Hans Clevers". Cell Stem Cell . 23 (6): 784–786. 2018. doi: 10.1016/j.stem.2018.11.004 . S2CID   239579550.
  7. 1 2 3 4 5 6 7 8 9 10 "CURRICULUM VITAE" (PDF). University of Utrecht. Archived from the original (PDF) on 23 June 2022. Retrieved 23 June 2022.
  8. 1 2 3 4 5 6 7 8 9 "Prof. Dr. Hans Clevers". Roche. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  9. 1 2 "Clevers: Adult stem cell-based organoids". University of Utrecht. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  10. 1 2 3 "Clevers group". Princess Máxima Center  [ nl ]. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  11. 1 2 3 4 Clevers, H. (2013). "A gutsy approach to stem cells and signalling: an interview with Hans Clevers". Disease Models & Mechanisms . 6 (5): 1053–1056. doi:10.1242/dmm.013367. PMC   3759325 . PMID   24046385. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  12. ↑ "Hans Clevers on Becoming a Scientist". Cold Spring Harbor Laboratory. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  13. ↑ Menkhorst, Roos (22 June 2013). "Ik leerde het belang van vertrouwen in mezelf". Trouw (in Dutch). Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  14. ↑ "Hans Clevers". Breakthrough Prize in Life Sciences. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  15. ↑ "Hans Clevers". Hubrecht Institute for Developmental Biology and Stem Cell Research. Archived from the original on 31 December 2011. Retrieved 15 March 2012.
  16. ↑ "Distinguished Lecture: Hans Clevers - "Gut Stem Cells, Organoids, and Precision Medicine". Columbia University. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  17. ↑ van Aartsen, Carina (26 March 2012). "Hans Clevers volgt KNAW-president Robbert Dijkgraaf op". Zorgvisie (in Dutch). Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  18. ↑ "President: Hans Clevers". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 1 February 2013.
  19. ↑ "New challenge for Hans Clevers at Roche". Hubrecht Institute for Developmental Biology and Stem Cell Research. 1 February 2022. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  20. ↑ "Changes to the Roche Board of Directors and the Corporate Executive Committee" (Press release). Basel: Roche. 1 February 2022. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  21. ↑ "Hans Clevers Group". Oncode Institute. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  22. ↑ "American Association for Cancer Research Councilors and Directors" (PDF). American Association for Cancer Research. Archived from the original (PDF) on 24 June 2022. Retrieved 24 June 2022.
  23. ↑ "Former SAB Members". Research Institute of Molecular Pathology. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  24. ↑ "Hans Clevers". Francis Crick Institute. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  25. ↑ "Advisory Board Biographies". The EMBO Journal. Archived from the original on 27 June 2022. Retrieved 24 June 2022.
  26. ↑ "Editors and Board". Disease Models & Mechanisms. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  27. ↑ "Staff and advisory board". Cell. Archived from the original on 27 June 2022. Retrieved 24 June 2022.
  28. ↑ "Advisory board". Cell Stem Cell. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  29. ↑ "Advisory Board Biographies". EMBO Molecular Medicine. Archived from the original on 27 June 2022. Retrieved 24 June 2022.
  30. ↑ "Hans Clevers, MD, PhD". Surrozen. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  31. ↑ "Surrozen to Present at Cowen and Company 40th Annual Health Care Conference". Surrozen (Press release). South San Francisco, California. 2 March 2020. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  32. ↑ "创始团队" (in Chinese). D1 Medical Technology. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  33. ↑ "丹望医疗完成数千万元天使轮融资，凯风创投领投". Sina (in Chinese). 8 February 2021. Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  34. ↑ Sinha, Gunjan (2017). "The organoid architect". Science. 357 (6353): 746–749. doi:10.1126/science.357.6353.746. PMID   28839056. Archived from the original on 28 June 2022. Retrieved 28 June 2022.
  35. ↑ van de Wetering, Marc; Oosterwegel, Mariette; Dooijes, Dennis; Clevers, Hans (1991). "Identification and cloning of TCF-1, a T cell-specific transcription factor containing a sequence-specific HMG box". The EMBO Journal. 10 (1): 123–132. doi:10.1002/j.1460-2075.1991.tb07928.x. PMC   452620 . PMID   1989880.
  36. ↑ Korinek, Vladimir; Barker, Nick; Moerer, Petra; van Donselaar, Elly; Huls, Gerwin; Peters, Peter J.; Clevers, Hans (1997). "Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4" . Nature Genetics . 19 (4): 379–383. doi:10.1038/1270. PMID   9697701. S2CID   1052683 . Retrieved 28 June 2022.
  37. ↑ Korinek, Vladimir; Barker, Nick; Morin, Patrice J.; van Wichen, Dick; de Weger, Roel; Kinzler, Kenneth W.; Vogelstein, Bert; Clevers, Hans (1997). "Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma" . Science . 275 (5307): 1784–1787. doi:10.1126/science.275.5307.1784. PMID   9065401. S2CID   33935423 . Retrieved 28 June 2022.
  38. ↑ Barker, Nick; van Es, Johan H.; Kuipers, Jeroen; Kujala, Pekka; van den Born, Maaike; Cozijnsen, Miranda; Haegebarth, Andrea; Korving, Jeroen; Begthel, Harry; Peters, Peter J.; Clevers, Hans (2007). "Identification of stem cells in small intestine and colon by marker gene Lgr5" . Nature . 449 (7165): 1003–1007. Bibcode:2007Natur.449.1003B. doi:10.1038/nature06196. PMID   17934449. S2CID   4349637 . Retrieved 23 June 2022.
  39. 1 2 Barker, Nick; Huch, Meritxell; Kujala, Pekka; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Abo, Arie; Peters, Peter J.; Wright, Nick; Poulsom, Richard; Clevers, Hans (2010). "Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro". Cell Stem Cell. 6 (1): 25–36. doi: 10.1016/j.stem.2009.11.013 . PMID   20085740.
  40. ↑ Jaks, Viljar; Barker, Nick; Kasper, Maria; van Es, Johan H; Snippert, Hugo J; Clevers, Hans; Toftgård, Rune (2008). "Lgr5 marks cycling, yet long-lived, hair follicle stem cells" . Nature Genetics. 40 (11): 1291–1299. doi:10.1038/ng.239. PMID   18849992. S2CID   10883817 . Retrieved 23 June 2022.
  41. ↑ Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Abo, Arie; Kujala, Pekka; Peters, Peter J.; Clevers, Hans (2009). "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche" . Nature. 459 (7244): 262–265. Bibcode:2009Natur.459..262S. doi:10.1038/nature07935. PMID   19329995. S2CID   4373784 . Retrieved 23 June 2022.
  42. ↑ Huch, Meritxell; Dorrell, Craig; Boj, Sylvia F.; van Es, Johan H.; van de Wetering, Marc; Li, Vivian S.W.; Hamer, Karien; Sasaki, Nobuo; Finegold, Milton J.; Haft, Annelise; Grompe, Markus; Clevers, Hans (2013). "In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration". Nature. 494 (7436): 247–250. Bibcode:2013Natur.494..247H. doi:10.1038/nature11826. PMC   3634804 . PMID   23354049.
  43. ↑ Sachs, Norman; de Ligt, Joep; Kopper, Oded; Gogola, Ewa; Bounova, Gergana; Weeber, Fleur; Vanita Balgobind, Anjali; Wind, Karin; Gracanin, Ana; Begthel, Harry; Korving, Jeroen; van Boxtel, Ruben; Alves Duarte, Alexandra; Lelieveld, Daphne; van Hoeck, Arne; Ernst, Robert Frans; Blokzijl, Francis; Nijman, Isaac Johannes; Hoogstraat, Marlous; van de Ven, Marieke; Egan, David Anthony; Zinzalla, Vittoria; Moll, Jurgen; Fernandez Boj, Sylvia; Voest, Emile Eugene; Wessels, Lodewyk; van Diest, Paul Joannes; Rottenberg, Sven; Vries, Robert Gerhardus Jacob; Cuppen, Edwin; Clevers, Hans (2018). "A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity". Cell . 172 (1–2): 373–386. doi: 10.1016/j.cell.2017.11.010 . PMID   29224780. S2CID   8951522.
  44. ↑ Kopper, Oded; de Witte, Chris J.; Lõhmussaar, Kadi; Valle-Inclan, Jose Espejo; Hami, Nizar; Kester, Lennart; Vanita Balgobind, Anjali; Korving, Jeroen; Proost, Natalie; Begthel, Harry; van Wijk, Lise M; Aristín Revilla, Sonia; Theeuwsen, Rebecca; van de Ven, Marieke; van Roosmalen, Markus J; Ponsioen, Bas; Ho, Victor W. H.; Neel, Benjamin G.; Bosse, Tjalling; Gaarenstroom, Katja N.; Vrieling, Harry; Vreeswijk, Maaike P. G.; van Diest, Paul J.; Witteveen, Petronella O.; Jonges, Trudy; Bos, Johannes L.; van Oudenaarden, Alexander; Zweemer, Ronald P.; Snippert, Hugo J. G.; Kloosterman 14, Hans Clevers, Wigard P. (2019). "An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity" . Nature Medicine . 25 (5): 838–849. doi:10.1038/s41591-019-0422-6. PMID   31011202. S2CID   126428230 . Retrieved 29 June 2022.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  45. ↑ Bartfeld, Sina (2021). "Realizing the potential of organoids—an interview with Hans Clevers". Journal of Molecular Medicine . 99 (4): 443–447. doi:10.1007/s00109-020-02025-3. PMC   8026466 . PMID   33464358.
  46. ↑ Bender, Eric (2015). "Q&A: Hans Clevers". Nature. 521 (7551): S15. Bibcode:2015Natur.521S..15B. doi: 10.1038/521S15a . PMID   25970453. S2CID   4452738.
  47. ↑ Saini, Angela (2016). "Cystic Fibrosis Patients Benefit from Mini Guts" (PDF). Cell Stem Cell. 19 (4): 425–427. doi:10.1016/j.stem.2016.09.001. Archived from the original (PDF) on 25 June 2022. Retrieved 26 June 2022.
  48. ↑ Lamers, Mart M; van der Vaart, Jelte; Knoops, Kèvin; Riesebosch, Samra; Breugem, Tim I; Mykytyn, Anna Z; Beumer, Joep; Schipper, Debby; Bezstarosti, Karel; Koopman, Charlotte D; Groen, Nathalie; Ravelli, Raimond B G; Duimel, Hans Q; Demmers, Jeroen A A; Verjans, Georges M G M; Koopmans, Marion P G; Muraro, Mauro J; Peters, Peter J; Clevers, Hans; Haagmans, Bart L (2021). "An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells". The EMBO Journal. 40 (5): e105912. doi:10.15252/embj.2020105912. PMC   7883112 . PMID   33283287.
  49. ↑ "Hans C. Clevers". European Molecular Biology Organization. Archived from the original on 26 June 2022. Retrieved 26 June 2022.
  50. ↑ "Hans Clevers". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 16 August 2019. Retrieved 16 August 2019.
  51. ↑ "NWO Spinoza Prize 2001". Dutch Research Council. Archived from the original on 31 October 2020. Retrieved 31 October 2020.
  52. ↑ "Professor Hans CLEVERS". Louis-Jeantet Foundation. October 2017. Archived from the original on 26 June 2022. Retrieved 26 June 2022.
  53. ↑ "Die Preisträger" (in German). Meyenburg Foundation. 30 April 2005. Archived from the original on 4 April 2022. Retrieved 26 June 2022.
  54. ↑ "Hans Clevers". Academia Europaea. Archived from the original on 26 June 2022. Retrieved 26 June 2022.
  55. ↑ "Awards & Grants : UEGF Research Prize : EUR 100.000 awarded for the most outstanding research programme". UEGW Barcelona 2010 : 18th United European Gastroenterology Week : Final Programme. United European Gastroenterology Federation (UEGF). 2010. p. 20. Archived from the original on 6 January 2024. Retrieved 6 January 2024.
  56. ↑ "Laureates 1976 to 2021". Ernst Jung Foundation. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  57. ↑ "William Beaumont Prize in Gastroenterology". American Gastroenterological Association. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  58. ↑ "Hans Clevers". Heineken Prizes. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  59. ↑ "Koninklijke onderscheidingen 2012" (in Dutch). Utrecht University. Archived from the original on 9 May 2015. Retrieved 9 May 2015.
  60. ↑ "NIEUWE LEDEN" (PDF). Jaarverslag 2012. Koninklijke Hollandsche Maatschappij der Wetenschappen. Archived from the original (PDF) on 27 June 2022. Retrieved 27 June 2022.
  61. ↑ "Hans Clevers". Breakthrough Prize in Life Sciences. Archived from the original on 14 February 2022. Retrieved 16 April 2022.
  62. ↑ "Hans Clevers". National Academy of Sciences. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  63. ↑ "Hans Clevers, MD, PhD". American Association for Cancer Research. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  64. ↑ "Hans Clevers" (in French). French Academy of Sciences. Archived from the original on 28 June 2022. Retrieved 27 June 2022.
  65. ↑ "Hans Clevers" (in German). Pour le Mérite für Wissenschaften und Künste. Archived from the original on 28 June 2022. Retrieved 27 June 2022.
  66. ↑ "Hans CLEVERS" (PDF). Pour le Mérite für Wissenschaften und Künste. Archived from the original (PDF) on 27 June 2022. Retrieved 27 June 2022.
  67. ↑ "Hans Clevers (2016): Replacement organs from a petri dish". Körber Foundation. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  68. ↑ "German award for Hans Clevers". Princess Máxima Center. 2 March 2018. Archived from the original on 27 June 2022. Retrieved 27 June 2022.
  69. ↑ "Hans Clevers". Royal Society. Archived from the original on 23 June 2022. Retrieved 23 June 2022.
  70. ↑ "Professor Johannes Carolus Clevers ForMemRS, HonFRSE". Royal Society of Edinburgh. Archived from the original on 1 August 2020. Retrieved 1 August 2020.
  71. ↑ "Hans C. Clevers" (in Japanese). Keio University. Archived from the original on 15 May 2020. Retrieved 27 June 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.